We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Roxro’s NSAID Nasal Spray Approved for Pain Relief
Roxro’s NSAID Nasal Spray Approved for Pain Relief
May 21, 2010
The FDA has approved Roxro Pharma’s nonsteroidal anti-inflammatory drug (NSAID) Sprix for short-term treatment (up to five days) of acute moderate to moderately severe pain that usually requires opioids.